echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Technical solution to the problem of purchasing subgroups of proprietary Chinese medicines and biological agents: Hebei once again enlightens us

    Technical solution to the problem of purchasing subgroups of proprietary Chinese medicines and biological agents: Hebei once again enlightens us

    • Last Update: 2022-11-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The underlying logic of product classification, looking for similarities or differences
    in nuances.
    From the era of procurement to the era of collective procurement of chemical drugs, biological drugs, proprietary Chinese medicines, high-value consumables and IVD reagents, the underlying logic and operation mode of product classification are still being explored, but the dawn
    has been seen.
    On November 1, Hebei announced the province's plan for hanging up proprietary Chinese medicines and biological agents, which has two major values: first, it solves the access problem of related enterprises that have not been able to enter the Hebei market for a long time, including proprietary Chinese medicines and biological agents, especially biosimilars that have been newly approved for marketing in recent years; Second, the grouping of proprietary Chinese medicines and biological agents has been solved at the technical level, which is the most critical
    .
    Let's start with the hanging method
    .

    Hanging the net is a procurement access method, which is currently parallel to the procurement method
    with volume.
    Many people who are not familiar with the recruitment standards have seen the rise and fall of national procurement and centralized procurement in various places in recent years, and have forgotten or do not know that there is still such a conventional procurement
    as hanging nets.
    A few days ago (October 28), Hebei also just announced the province's chemical drugs and biological agents with volume procurement plan, so it is a special reminder that the procurement project mentioned today is a hanging network, not a volume procurement
    .
    In fact, most drugs are still priced and selected for admission to the hospital
    by hanging on the Internet.

    Hanging the network, involving grouping, reference price, and price difference problems, solved these basic conversion problems, and it is possible to achieve subsequent operations
    .

    Group first press the table to see the price
    .

    The hanging network plan stipulates that if the exclusive generic name is newly applied for hanging on the network, if there are 3 provinces with the hanging price, the lowest price in the country; If there are ≥ 2 in the same group The maximum price difference in the calculation of the difference ratio is generally not more than 3 times, and it ≤ the lowest price
    of this product in the country.
    It can be seen that all provinces use the lowest price in the country as the de facto limit price, and Hebei uses the price difference of 3 times as a regulation index this time, respecting the price difference
    between more than ≥ 2 manufacturers.
    In addition, the idea of using the average daily maximum and minimum dosage of proprietary Chinese medicines as a measure of quotation is reflected in the Guangdong Proprietary Chinese Medicine Alliance, and seems to have become a way of
    quoting proprietary Chinese medicines.

    Although the daily treatment cost is a very objective and fair method, the problem is that the key information such as the instructions and usage and dosage of proprietary Chinese medicines vary greatly due to various reasons, and it is difficult to calculate the daily treatment cost
    in the same way.
    So, what about Hebei?

    Hebei's practice is based on the usage and dosage of different varieties, divided into: children and adults, accurate use according to weight, usage and dosage changes with the course of the disease, multiple indications, unspecified indications, and unspecified usage and dosage to formulate corresponding declaration methods
    .
    This idea is really the first in Hebei and deserves great praise, not only solving the problems of large differences in the instructions, usage and dosage of proprietary Chinese medicines, and inconsistent standards, but also continuing to solve industry problems and innovations
    on the basis of daily treatment costs.
    It is worth learning and thinking about the algorithm of daily treatment costs, in the grouping, Hebei also lists in detail the situation
    that various drugs can be divided into groups and groups.
    Different groups of proprietary Chinese medicines divide the problems into several situations
    , such as different sources of bezoar musk, different formulas of the same name, and different dosage forms (external use).
    In the price comparison table of the same group of proprietary Chinese medicines, the problems are divided into: different sources of bezoar musk, children's medication, whether it contains sugar, different groups with the same name, different names and the same side, different names, the same main side is slightly adjusted, and the dosage form is different (external use).

    Note that merge grouping and differential grouping have different roles in
    each factor.
    If the categories are not clearly defined, it will inevitably lead to a series of problems
    such as incomparable prices.

    For example, the same natural and artificial differences, bezoar is treated in the same group, such as Angong beef yellow pills, while musk is distinguished
    .

    It is also to relieve the muscles and activate blood, but according to whether the group is the same to judge, tablets and capsules can be separated, and pills, tablets and capsules can also be divided into different groups
    .

    The generic name is the same, and the dosage forms such as granules and oral liquid agents do not distinguish whether they contain sugar;

    Such a meticulous grouping basically solves the problem of category division that has plagued the industry for many years, which is a major technical contribution
    of Hebei to the industry.

    Therefore, in Hubei, Shandong proprietary Chinese medicine collection and other projects, some products have entered, but a certain dosage form under the generic name (large sales) has repeatedly avoided centralized procurement, when we are puzzled, whether to come back to Hebei these grouping methods, and study the instructions, formulas, pharmacopoeias, and registration information of various varieties, should be very enlightening
    .
    The following is the grouping of various products, let's take a good look
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.